|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
|
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| CURRENT ASSETS: | ||||||
| Cash and cash equivalents | ||||||
| Investments | ||||||
| Prepaid expenses and other current assets | ||||||
| Total current assets | ||||||
| Property and equipment, net | ||||||
| Investments | ||||||
| Operating lease right-of-use assets | ||||||
| Other long-term assets | ||||||
| Restricted cash | ||||||
| TOTAL ASSETS | ||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||
| CURRENT LIABILITIES: | ||||||
| Accounts payable | ||||||
| Accrued expenses and other current liabilities | ||||||
| Operating lease liabilities | ||||||
| Total current liabilities | ||||||
| Long-term operating lease liabilities | ||||||
| TOTAL LIABILITIES | ||||||
| COMMITMENTS AND CONTINGENCIES (Note 13) | ||||||
| Preferred stock | ||||||
| STOCKHOLDERS’ EQUITY | ||||||
| Preferred stock - $0.0001 par value, 10,000,000 shares authorized as of September 30, 2020 and December 31, 2019, respectively; no shares issued as of September 30, 2020 and December 31, 2019, respectively | ||||||
| Common stock - $0.0001 par value, 200,000,000 shares authorized as of September 30, 2020 and December 31, 2019, respectively, 34,245,433 and 34,138,750 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively | ||||||
| Additional paid-in capital | ||||||
| Accumulated deficit | ||||||
| Accumulated other comprehensive income | ||||||
| Total stockholders’ equity | ||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY |
Loading...
